,0
Name,"APELLIS PHARMACEUTICALS, INC."
Currency,USD
Sector,Healthcare
Industry,Biotechnology
Country,US
IPO,"Nov 9, 2017"
Insider Percentage,16.18%
Institution Percentage,78.14%
